Article
Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.
British journal of haematology - 1 Sept 2003
Zorio Esther, Castelló Remedios, Falcó Cristina, España Francisco, Osa Ana, Almenar Luis, Aznar Justo, Estellés Amparo
Abstract excerpt
Thrombin-activatable fibrinolysis inhibitor (TAFI) is a fibrinolytic inhibitor. Studies in coronary artery disease have reported increased TAFI activity (TAFI Act) and low TAFI antigen (TAFI Ag) levels. This controversy might be explained by the polymorphisms of its gene. Only the Thr325Ile polymorphism modulates both TAFI Ag and Act levels in vitro. This study assessed TAFI Ag and Act levels, TAFI Thr325Ile...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
